Oncothyreon Reports Full Year and Fourth Quarter 2014 Financial Results

Go back to Oncothyreon Reports Full Year and Fourth Quarter 2014 Financial Results

Oncothyreon (ONTY) Misses Q4 EPS by 21c

March 10, 2015 4:02 PM EDT

Oncothyreon (NASDAQ: ONTY) reported Q4 EPS of ($0.30), $0.21 worse than the analyst estimate of ($0.09).

As of December 31, 2014, Oncothyreon's cash, cash equivalents and investments were $63.7 million, compared to $72.6 million at December 31, 2013, a decrease of $8.9 million, or 12.3 percent. The decrease was primarily attributable to $48.4... More